首页> 美国卫生研究院文献>other >Coupled gel spreading and diffusive transport models describing microbicidal drug delivery
【2h】

Coupled gel spreading and diffusive transport models describing microbicidal drug delivery

机译:耦合的凝胶扩散和扩散运输模型描述了杀菌药物的传递

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Gels are a drug delivery platform that is being evaluated for application of active pharmaceutical ingredients, termed microbicides, that act topically against vaginal and rectal mucosal infection by sexually transmitted HIV. Despite success in one Phase IIb trial of a vaginal gel delivering tenofovir, problems of user adherence to designed gel application scheduling have compromised results in two other trials. The microbicides field is responding to this dilemma by expanding behavioral analysis of the determinants of adherence while simultaneously improving the pharmacological, biochemical, and biophysical analyses of the determinants of microbicide drug delivery. The intent is to combine results of these two complementary perspectives on microbicide performance and epidemiological success to create an improved product design paradigm. Central to both user sensory perceptions and preferences, key factors that underlie adherence, and to vaginal gel mucosal drug delivery, that underlies anti-HIV efficacy, are gel properties (e.g. rheology) and volume. The specific engineering problem to be solved here is to develop a model for how gel rheology and volume, interacting with loaded drug concentration, govern the transport of the microbicide drug tenofovir into the vaginal mucosa to its stromal layer. These are factors that can be controlled in microbicide gel design. The analysis here builds upon our current understanding of vaginal gel deployment and drug delivery, incorporating key features of the gel’s environment, the vaginal canal, fluid production and subsequent gel dilution, and vaginal wall elasticity. These have not previously been included in the modeling of drug delivery. We consider the microbicide drug tenofovir, which is the drug most completely studied for gels: in vitro, in animal studies in vivo, and in human clinical trials with both vaginal or rectal gel application. Our goal is to contribute to improved biophysical and pharmacological understanding of gel functionality, providing a computational tool that can be used in future vaginal microbicide gel design.
机译:凝胶是一种药物递送平台,正在评估其活性药物成分(称为杀微生物剂)的应用,该成分可局部抵抗由性传播的HIV引起的阴道和直肠粘膜感染。尽管在一项IIbb期阴道凝胶递送替诺福韦的试验中取得了成功,但用户对设计的凝胶施用时间表的依从性问题在另外两项试验中均受到影响。杀微生物剂领域通过扩大对依从性决定因素的行为分析,同时改善了对杀微生物剂药物传递决定因素的药理学,生化和生物物理分析,来应对这一难题。目的是将关于杀微生物剂性能和流行病学成功的这两个互补观点的结果结合起来,以创建一种改进的产品设计范例。对于使用者的感官知觉和喜好而言,依从性的关键因素以及作为抗HIV功效基础的阴道凝胶粘膜药物传递的关键因素是凝胶特性(例如流变学)和体积。这里要解决的具体工程问题是建立一个模型,用于研究凝胶流变学和体积如何与负载的药物浓度相互作用,控制杀微生物剂替诺福韦进入阴道粘膜到其基质层的运输。这些是杀菌剂凝胶设计中可以控制的因素。此处的分析基于我们对阴道凝胶部署和药物输送的当前理解,结合了凝胶环境,阴道管,分泌液和随后的凝胶稀释以及阴道壁弹性的关键特征。这些以前未包括在药物输送模型中。我们考虑使用杀微生物药物替诺福韦,这是对凝胶进行最全面研究的药物:体外,体内动物研究以及应用阴道或直肠凝胶的人体临床试验。我们的目标是促进对凝胶功能的生物物理和药理学理解,提供可用于未来阴道杀菌剂凝胶设计的计算工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号